Patient P-02685

Synthetic patientMETA-24 · Day 172 · 75+ · M · baseline S16Steering view · 3D Open companion preview

Therapy response

Declining

Tolerance

Favorable

GI state

Deteriorating

Inflammatory state

Favorable

Nutritional resilience

Favorable

Discontinuation risk

24%

Trajectory

Baseline → today → 30-day prediction · hover a day for signals and events

solid = observed · dashed = predicted

Day 0 META-24 started — Baseline state S16
Day 13 Trajectory diverged from prediction — Observed response fell below the model's expected path.
Day 22 DT-01 recommended — Dosing / Timing Recommendation DT-01
Day 23 Patient accepted — Started DT-01 in the companion
Day 28 GI symptom burden −18% vs expected — Dosing / Timing Recommendation DT-01
Day 34 Tolerance state changed — Unstable → Improving

What changed?

Trajectory began diverging from predicted response on Day 13.

Primary contributors, last 14 days

GI instability+5
Treatment adherence-4
Inflammatory activity+3
Toxicity-2

What helped?

Dosing / Timing Recommendation DT-01Day 22
Result: symptom burden −18%

LIFE OS recommendation

No intervention is indicated right now. The trajectory is stable relative to similar patients. See what worked for similar patients.

Daily trackers

Molecule settings

The trackers this program marks as important, last 14 days vs the 14 before.

Active minutes

Wearable

90 min

stable · +1.7 vs previous 14 d

Sleep duration

Wearable

7.9 h

stable · -0.3 vs previous 14 d

Energy level

Daily log

5.8/10

worsening · -0.3 vs previous 14 d

Steps

Wearable

10,062

stable · +25 vs previous 14 d

GI burden

Companion

23.8/100

worsening · +4.5 vs previous 14 d

Adherence

Companion

92.4 %

stable · -3.6 vs previous 14 d

Sleep quality

Wearable

73.1/100

worsening · -7.3 vs previous 14 d

Glucose, CGM daily mean

CGM

126 mg/dL

stable · +0.9 vs previous 14 d

This trajectory is decaying — what would help, what would not

Steering view →

Heading towards failing · 61 from the failing basin, 33 from restoration.

Would help

No untried action with strong evidence. Compose one from primitives.
More protein
GI -3.7 next day on high-intake days · n 21

Would not help

BR-03 Behavioural Recommendation
only 13% improved among 8 similar
Keep simple carbs low
GI +3.1 next day on high-intake days · n 29
Keep ultra-processed low
GI +2.9 next day on high-intake days · n 18

State influencers · digestive

Next-day GI change on high-intake vs low-intake days, last 60 days. Attribution from this patient's own log; sensitivity set by their biology.

Protein
-3.7supporter · 95%
Simple carbohydrates
+3.1detractor · 95%
Ultra-processed food
+2.9detractor · 95%
Insoluble fibre
+0.3no signal · 15%
Dietary fat load
+0.2no signal · 15%
Caffeine
-0.2no signal · 15%
Histamine load
-0.1no signal · 15%
Alcohol
0no signal · 15%

Biological layers

Which pathways look influenced, and by which layer of this person's biology.

Pathways under pressure

Mucosal barrier integrity ↓30
- MicrobiomeAkkermansia low → thinner mucus layer
Autonomic recovery ↓25
- WearableResting HR 75 bpm

DNA

Fictional pharmacogenomic panel

CYP2D6 Normal metabolizer
Expected exposure

Microbiome

Shannon diversity 2.6 · butyrate capacity 48/100

Akkermansia muciniphilaLow
Faecalibacterium prausnitziiNormal
Bacteroides fragilisNormal
Bifidobacterium longumLow
EnterobacteriaceaeHigh

Wearable, last 14 days

daily evolution fed into the runtime

HRV: 65 ms
Sleep: 7.6 h
Steps: 9,911
Resting HR: 77 bpm

Daily log: GI score 24, nutritional resilience 65, adherence 92.

What this patient sees in NostraAI

The content that steers the trajectory: what to eat, what to do, what to take.

Open companion preview

What to eat

Keep meals regular; three to four moderate portions spaced through the day
Include a cooked vegetable portion with each main meal
Keep fibre steady; no new sources this week
Eat slowly and stop at comfortable fullness — smaller volume, more often

What to do

Log the daily check-in; one line is enough
Keep the current walking rhythm
Keep the sleep window steady
Keep hydration steady: small amounts through the day rather than large volumes at once

What to take

Take the dose at the same time relative to your evening meal
No additional supplements this week
Fictional demo item: continue vitamin D as before

284 biologically similar trajectories

Black: this patient. Green: similar patients whose intervention worked. Orange: similar patients where it did not.

Patient	Similarity	Baseline	Intervention	Outcome	Response today
P-02031	37%	S12	AD-05	improved	47
P-02093	36%	S05	AD-05	no change	40
P-02285	36%	S14	AD-05	no change	39
P-02087	40%	S01	BR-03	no change	40
P-02280	38%	S07	BR-03	no change	50
P-02483	37%	S06	BR-03	no change	64
P-02522	37%	S01	BR-03	no change	40
P-02638	37%	S01	BR-03	improved	41
P-02267	36%	S09	BR-03	no change	45
P-02308	33%	S13	BR-03	no change	27
P-02439	32%	S08	BR-03	no change	40
P-02339	49%	S03	DT-01	improved	50